NEOADJUVANT
Clinical trials for NEOADJUVANT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT trials appear
Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop kidney cancer from coming back
Disease control Recruiting nowThis study is testing whether giving two cancer drugs (axitinib and a PD-1 antibody) before surgery can help stop kidney cancer from returning. It will involve 298 patients with high-risk kidney cancer who are scheduled for surgery. Patients will be randomly assigned to receive e…
Matched conditions: NEOADJUVANT
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated Mar 31, 2026 12:13 UTC
-
New targeted attack on advanced ovarian cancer shows promise
Disease control Recruiting nowThis study is testing whether a new targeted drug called mirvetuximab soravtansine, when combined with standard chemotherapy (carboplatin), can shrink tumors before surgery in people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The treatment is designed to…
Matched conditions: NEOADJUVANT
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for esophageal cancer patients: trial tests powerful Pre-Surgery combo
Disease control Recruiting nowThis study is testing a new combination of drugs given before surgery for people with a type of esophageal cancer that can be surgically removed but is locally advanced. The goal is to see if adding a newer immunotherapy drug (AK112) to standard chemotherapy drugs helps shrink th…
Matched conditions: NEOADJUVANT
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC